Dr. Michael P. Alexander

Anesthesiology
Chs Anesthesia Services Group Inc
920 Church St N, 
Concord, NC 
Clinical Trials:Currently Recruiting for 1 Trial
Chs Anesthesia Services Group Inc
920 Church St N, 
Concord, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Alexander is an Anesthesiologist in Concord, North Carolina. His top areas of expertise are Gallbladder Disease and Angiomyoma.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Anesthesiology
Licenses
Anesthesiology in NC
Hospital Affiliations
Carolinas Medical Center-Northeast
Atrium Health University City
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

CHS ANESTHESIA SERVICES GROUP INC
920 Church St N, Concord, NC 28025
Other Locations
CHS ANESTHESIA SERVICES GROUP INC
8800 N Tryon St, Charlotte, NC 28262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Carboplatin, Cisplatin, Gemcitabine Hydrochloride, Paclitaxel, Pembrolizumab, Pemetrexed Disodium
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Device, Other, Procedure
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).
ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms With the Next Generation Neuroform Stent System
Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms With the Next Generation Neuroform Stent System
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Device
Study Phase: Not Applicable
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Enrollment Status: Completed
Publish Date: December 02, 2019
Intervention Type: Device
Study Phase: Not Applicable
EDAS (Surgical) Revascularization for Symptomatic Intracranial Arterial Stenosis
EDAS (Surgical) Revascularization for Symptomatic Intracranial Arterial Stenosis
Enrollment Status: Completed
Publish Date: May 10, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 12 Less Clinical Trials

19 Total Publications

Subjective Cognitive Complaints in Concussion.
Subjective Cognitive Complaints in Concussion.
Journal: Journal of neurotrauma
Published: August 14, 2019
Similar Doctors
Expertise in
7
conditions
Dr. Leonardo Kapural
Anesthesiology | Pain Medicine
Expertise in
7
conditions
Dr. Leonardo Kapural
Anesthesiology | Pain Medicine

Carolinas Pain Institute, PA

145 Kimel Park Dr, Suite 330, 
Winston Salem, NC 
 (46.2 miles away)
336-765-6181
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Leonardo Kapural is an Anesthesiologist and a Pain Medicine provider in Winston Salem, North Carolina. Dr. Kapural is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic Pain, Phantom Limb Pain, Neuralgia, Acute Pain, and Hepato-Pancreato-Biliary Surgery. Dr. Kapural is currently accepting new patients.

Expertise in
5
conditions
Dr. Richard L. Rauck
Pain Medicine | Anesthesiology
Expertise in
5
conditions
Dr. Richard L. Rauck
Pain Medicine | Anesthesiology

Carolinas Pain Institute, PA

145 Kimel Park Dr, Suite 330, 
Winston Salem, NC 
 (46.2 miles away)
336-765-6181
Experience:
43+ years
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Richard Rauck is a Pain Medicine specialist and an Anesthesiologist in Winston Salem, North Carolina. Dr. Rauck has been practicing medicine for over 43 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Chronic Pain, Acute Pain, Neuralgia, and Complex Regional Pain Syndrome. Dr. Rauck is currently accepting new patients.

Expertise in
9
conditions
Dr. Stephen B. Pociask
Anesthesiology | Pain Medicine
Expertise in
9
conditions
Dr. Stephen B. Pociask
Anesthesiology | Pain Medicine
1665 Herlong Ct, Suite B, 
Rock Hill, SC 
 (42.2 miles away)
877-524-1083
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephen Pociask is an Anesthesiologist and a Pain Medicine provider in Rock Hill, South Carolina. Dr. Pociask is highly rated in 9 conditions, according to our data. His top areas of expertise are Chronic Pain, Cervical Spondylosis, Invertebral Disc Disease, and Sacroiliac Joint Disease. Dr. Pociask is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alexander's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile